The impact of anxiety level on the outcome of alopecia therapy in women
- Authors: Titarenko Y.B.1, Haldina M.V.1
-
Affiliations:
- Mudrov International Institute of Integrative Methods in Aesthetic and Anti-Aging Medicine, LLC
- Issue: Vol 27, No 6 (2025): Dermatology and allergology
- Pages: 348-351
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/309789
- DOI: https://doi.org/10.26442/20751753.2025.6.203238
- ID: 309789
Cite item
Full Text
Abstract
Background. Alopecia is a common dermatological condition associated with significant psychological stress, particularly in women. Anxiety frequently accompanies this condition, negatively impacting quality of life and treatment outcomes.
Aim. To assess anxiety levels in women with androgenetic and alopecia areata and their dynamics during therapy with the anxiolytic drug temgikoluril (Adaptol).
Materials and methods. The study included 42 patients in the main group and 40 in the control group. Anxiety levels were assessed using the Hospital Anxiety and Depression Scale-Anxiety Subscale at baseline, 6 weeks, and 12 weeks. The main group received temgikoluril in addition to standard alopecia therapy.
Results. In the main group, anxiety levels significantly decreased at 6 weeks and continued to decline at 12 weeks. In the control group, anxiety reduction was less pronounced. Both groups showed positive trichological dynamics, but the main group reported better emotional state and reduced focus on hair loss issues.
Conclusion. Anxiolytic therapy with temgikoluril significantly reduces anxiety levels in patients with alopecia, improving treatment satisfaction, which highlights the importance of a comprehensive approach to alopecia management.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Yuliana B. Titarenko
Mudrov International Institute of Integrative Methods in Aesthetic and Anti-Aging Medicine, LLC
Author for correspondence.
Email: trance2002@mail.ru
ORCID iD: 0009-0002-8581-2966
Cand. Sci. (Med.)
Russian Federation, MoscowMaria V. Haldina
Mudrov International Institute of Integrative Methods in Aesthetic and Anti-Aging Medicine, LLC
Email: trance2002@mail.ru
ORCID iD: 0009-0007-7560-5601
Cand. Sci. (Med.)
Russian Federation, MoscowReferences
- Jamerson TA, Aguh C. An approach to patients with alopecia. Med Clin North Am. 2021;105(4):599-610. doi: 10.1016/j.mcna.2021.04.002
- Тости А., Аз-Сигала Д., Пирмеза Р. Лечение волос и кожи головы. Под ред. А.Г. Гаджигороевой. М.: ГЭОТАР-Медиа, 2023 [Tosti A, Az-Sigala D, Pirmeza R. Lechenie volos i kozhi golovy. Pod red. AG Gadzhigoroevoi. Moscow: GEOTAR-Media, 2023 (in Russian)].
- Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol. 2001;116(3):452-5. doi: 10.1046/j.1523-1747.2001.01261.x
- Снарская Е.С., Гришина В.Б. Диффузная алопеция и метод ее комплексной коррекции. Российский журнал кожных и венерических болезней. 2015;18(4):49-55 [Snarskaya ES, Grishina VB. Diffuse alopecia and a method for its complex correction. Rossiyskiy Zhurnal Kozhnykh i Venericheskikh Bolezney. 2015;18(4):49-55 (in Russian)].
- Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: A comprehensive review. Autoimmun Rev. 2015;14(2):81-9. doi: 10.1016/j.autrev.2014.10.014
- Hunt N, McHale S. The psychological impact of alopecia. BMJ. 2005;331(7522):951-3. doi: 10.1136/bmj.331.7522.951
- Katsarou-Katsari A, Singh LK, Theoharides TC. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology. 2001;203(2):157-61. doi: 10.1159/000051732
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70. PMID: 6880820
Supplementary files
